Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-047184
Filing Date
2025-03-31
Accepted
2025-03-31 06:45:31
Documents
120
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jagx-20241231.htm   iXBRL 10-K 6049286
2 EX-19.1 jagx-ex19_1.htm EX-19.1 76660
3 EX-21.1 jagx-ex21_1.htm EX-21.1 8309
4 EX-23.1 jagx-ex23_1.htm EX-23.1 9160
5 EX-31.1 jagx-ex31_1.htm EX-31.1 13332
6 EX-31.2 jagx-ex31_2.htm EX-31.2 13166
7 EX-32.1 jagx-ex32_1.htm EX-32.1 7814
8 EX-32.2 jagx-ex32_2.htm EX-32.2 8377
9 GRAPHIC img31428190_0.jpg GRAPHIC 5052
10 GRAPHIC img74763524_0.jpg GRAPHIC 189666
11 GRAPHIC img74763524_1.jpg GRAPHIC 19283
  Complete submission text file 0000950170-25-047184.txt   23863665

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT jagx-20241231.xsd EX-101.SCH 2568798
123 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20241231_htm.xml XML 4877446
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36714 | Film No.: 25788753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)